QHSLab, Inc. (USAQ)
OTCMKTS · Delayed Price · Currency is USD
0.2130
+0.0230 (12.11%)
Oct 17, 2025, 1:38 PM EDT
QHSLab Market Cap
QHSLab has a market cap or net worth of $2.14 million as of October 17, 2025. Its market cap has increased by 300.31% in one year.
Market Cap
2.14M
Enterprise Value
3.57M
Revenue
2.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.21
Market Cap Chart
Since March 1, 1995, QHSLab's market cap has decreased from 23.47M to 2.14M, a decrease of -90.87%. That is a compound annual growth rate of -7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 2.14M | -18.41% |
| Dec 31, 2024 | 2.63M | 199.84% |
| Dec 26, 2023 | 876.20K | -42.65% |
| Dec 30, 2022 | 1.53M | -76.10% |
| Dec 31, 2021 | 6.39M | 110.36% |
| Dec 31, 2020 | 3.04M | 1,666.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |